手机扫码访问本站
微信咨询
技术规格
Background:
NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.
Applications:
WB, IHC, IF
Name of antibody:
RELA(phospho-Ser311)
Immunogen:
Peptide sequence around phosphorylation site of serine 311(F-K-S(p)-I-M) derived from Human NFκB-p65.
Full name:
v-rel avian reticuloendotheliosis viral oncogene homolog A
Synonyms:
p65; NFKB3
SwissProt:
Q04206
IHC positive control:
Human breast carcinoma tissue
IHC Recommend dilution:
50-100
WB Predicted band size:
60 kDa
WB Positive control:
Hela cells lysates untreated or treated with IFN-α
WB Recommended dilution:
500-1000
IF positive control:
Hela cells
IF Recommend dilution:
100-200